References
- Nadir Y, Brenner B. Hemorrhagic and thrombotic complications in bone marrow transplant recipients. Thromb Res. 2007;120 Suppl 2:S92–8.
- Pihusch M. Bleeding complications after hematopoietic stem cell transplantation. Semin Hematol. 2004;41(1 Suppl 1):93–100.
- Graf L, Stern M. Acute phase after hematopoietic stem cell transplantation. Bleeding and thrombotic complications. Hamostaseologie. 2012;32:1–7.
- Pihusch R, Salat C, Schmidt E, Gobring P, Pihusch M, Hiller E, et al.. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation. 2002;74:1303–9.
- Miano M, Faraci M, Dini G, Mardigoni P, on behalf of the EBMT Paediatric Working Party. Early complications following haematopoietic SCT in children. Bone Marrow Transplant. 2008;41:S39–42.
- Paz IB. Vascular access and complications. In: , Appelbaum F R, Forman S J, Negrin R S, Blume K G, ed, editors. Thomas’s hematopoietic cell transplantation, ed. Oxford: Wiley-Blackwell; 2008. p. 1244–56.
- Gonsalves A, Carrier M, Wells PS, McDiarmid SA, Huebsch LB, Allan DS. Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation. J Thromb Haemost. 2008;6:1468–73.
- Strasser SI, Mc Donald GB. Gastrointestinal and hepatic complications. In: , Appelbaum F R, Forman S J, Negrin R S, Blume K G, ed, editors. Thomas’s hematopoietic cell transplantation, ed. Oxford: Wiley-Blackwell; 2008. p. 1434–55.
- Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al.. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010;16:157–68.
- Vassal G, Koscielny S, Challine D, Valteau-Couanet D, Boland I, Deroussent A, et al.. Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation. Cancer Chemother Pharmacol. 1996;37:247–53.
- Hasegawa S, Horibe K, Kawabe T, Kato K, Kojima S, Matsuyama T, et al.. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors. Bone Marrow Transplant. 1998;22:1191–7.
- Pihusch V, Pihusch M, Penovici M, Kolb HJ, Hiller E, Pihusch R. Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoietic stem cell transplantation. Thromb Res. 2005;116:233–40.
- Ho VT, Revta C, Richardson PG. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone Marrow Transplant. 2008;41:229–37.
- Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, et al.. Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. Biol Blood Marrow Transplant. 2010;16:1005–17.
- Sullivan KM, Kansu E, Storer B, Jocom J, Emerson G, Reagan T, et al.. Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation. Biol Blood Marrow Transplant. 1998;41:20–6.
- Batts ED, Lazarus HM. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant. 2007;40:709–19.
- Laskin BL, Goebel J, Davies SM, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood. 2011;118:1452–62.
- Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ, et al.. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation. 2010;90:918–26.